Financial accounts reports

David Citron

DOI:https://doi.org/10.5912/jcb60

Abstract:

Antisoma, founded in 1988, specialises in the development of novel anti-cancer drugs. Its strategy is to focus on the middle pre-clinical and clinical development stages rather than on either the relatively risky initial discovery or costly marketing stages.

Keywords:en ,